Amended Report of Foreign Issuer (6-k/a)
October 25 2013 - 4:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 6-K/A
Amendment No. 1 to
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the
month of August 2013
Commission File Number: 001-34541
CHINA
CORD BLOOD CORPORATION
(Translation of registrant’s name into English)
48
th
Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong S.A.R.
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F
x
Form 40-F
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Indicate by check mark whether the registrant
by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule
12g3-2(b) under the Securities Exchange Act of 1934.
Yes
¨
No
x
If “Yes” is marked, indicate
below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.
EXPLANATORY NOTE
Th
is
Amendment No. 1 (the “Amendment”) to the Report of Foreign Issuer on Form 6-K (the “Original
6-K”), originally furnished by China Cord Blood Corporation (the “Company”) to the Securities and Exchange
Commission on August 26, 2013, amends the Original 6-K to include the interactive data file as Exhibit 101, which provides
the unaudited condensed consolidated financial statements contained in the Original 6-K in XBRL (eXtensible business
reporting language) and to provide for the incorporation by reference described below. No other changes have been made to the
Original 6-K. This Amendment does not reflect events that may have occurred subsequent to the original submission date and
does not modify or update in any way the disclosures made in the Original 6-K.
This Amendment
and each of the exhibits to this Amendment are hereby incorporated by reference into the registration statement on Form F-3 (No.
333-191121) of the Company.
Exhibits
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
99.1*
|
|
Press Release, dated August 26, 2013
|
|
101.INS XBRL
|
|
Instance Document
|
|
101.SCH XBRL
|
|
Taxonomy Extension Schema Document
|
|
101.CAL XBRL
|
|
Taxonomy Extension Calculation Linkbase Document
|
|
101.LAB XBRL
|
|
Taxonomy Extension Label Linkbase Document
|
|
101.PRE XBRL
|
|
Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
* Previously filed.
|
|
|
|
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
CHINA CORD BLOOD CORPORATION
|
|
|
|
By:
|
/s/
Albert Chen
|
|
Name:
|
Albert Chen
|
|
Title:
|
Chief Financial Officer
|
Dated:
October 25, 2013
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From May 2024 to Jun 2024
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Jun 2023 to Jun 2024